Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amcenestrant vs Letrozole + Palbociclib in Advanced Breast Cancer (AMEERA-5)
NCT04478266Phase 3Terminated
- Sponsor
- Sanofi
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 3 trial of amcenestrant in breast cancer, sponsored by Sanofi. Started Oct 2020; status: terminated.
02
Drugs
amcenestrant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04478266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04478266.